Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.59M | 11.62M | 12.64M | 10.85M | 9.05M |
| Total Depreciation and Amortization | 2.22M | 2.37M | 2.51M | 2.31M | 2.10M |
| Total Amortization of Deferred Charges | 514.40K | 284.90K | 56.20K | 56.20K | 56.20K |
| Total Other Non-Cash Items | 2.08M | 686.10K | -697.50K | -217.20K | 262.30K |
| Change in Net Operating Assets | -6.87M | -2.85M | 1.16M | 1.16M | 1.16M |
| Cash from Operations | 8.54M | 12.11M | 15.67M | 14.15M | 12.63M |
| Capital Expenditure | -4.88M | -6.26M | -7.64M | -7.64M | -7.64M |
| Sale of Property, Plant, and Equipment | 17.80K | 8.90K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.70M | -10.42M | -4.15M | -3.12M | -2.09M |
| Cash from Investing | -21.56M | -16.67M | -11.79M | -10.76M | -9.73M |
| Total Debt Issued | 75.54M | 62.31M | 49.09M | 49.09M | 49.09M |
| Total Debt Repaid | -21.73M | -20.18M | -18.63M | -18.63M | -18.63M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -24.83M | -15.00M | -5.17M | -5.17M | -5.17M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.19M | 11.36M | 23.90M | 11.56M | -783.00K |
| Cash from Financing | 3.56M | 4.92M | 6.29M | 4.71M | 3.13M |
| Foreign Exchange rate Adjustments | 1.21M | -766.20K | -2.74M | -2.40M | -2.07M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.26M | -403.00K | 7.43M | 5.70M | 3.97M |